Liminatus Pharma, Inc.
LIMN
$0.18
$0.00-2.17%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 337.70K | 724.50K | 1.34M | -- | 56.30K |
| Total Receivables | -- | -- | -- | -- | 3.67M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 162.90K | 478.90K | 444.10K | -- | 155.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 1.40M |
| Total Current Assets | 500.60K | 1.20M | 1.78M | -- | 5.28M |
|
|
|||||
| Total Current Assets | 500.60K | 1.20M | 1.78M | -- | 5.28M |
| Net Property, Plant & Equipment | 12.20K | 12.80K | 200.00 | -- | 900.00 |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 126.30K | 126.30K | -- | 126.30K |
| Total Assets | 512.80K | 1.34M | 1.91M | -- | 5.41M |
|
|
|||||
| Total Accounts Payable | 582.20K | 559.20K | 431.90K | -- | 1.48M |
| Total Accrued Expenses | 203.90K | 184.90K | 165.80K | 1.10K | 3.10M |
| Short-term Debt | 1.44M | 1.44M | 1.44M | -- | 19.97M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 8.07M | 678.10K | 8.48M | -- | 195.30K |
| Total Other Current Liabilities | 8.07M | 678.10K | 8.48M | -- | 195.30K |
| Total Current Liabilities | 10.30M | 2.86M | 10.52M | 1.10K | 24.75M |
|
|
|||||
| Total Current Liabilities | 10.30M | 2.86M | 10.52M | 1.10K | 24.75M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.44M | 1.44M | 1.44M | -- | 19.97M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 29.20K | 123.60K | 200.50K | -- | -- |
| Total Liabilities | 10.33M | 2.99M | 10.72M | 1.10K | 24.75M |
|
|
|||||
| Common Stock & APIC | 29.06M | 29.06M | 20.07M | 0.00 | 9.33M |
| Retained Earnings | -38.87M | -30.70M | -28.88M | -1.10K | -28.67M |
| Treasury Stock & Other | -- | -- | -- | 0.00 | -- |
| Total Common Equity | -9.81M | -1.65M | -8.81M | -1.10K | -19.34M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.81M | -1.65M | -8.81M | -1.10K | -19.34M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.81M | -1.65M | -8.81M | -1.10K | -19.34M |
|
|
|||||